Advances in the Treatment of Spinal Muscular Atrophy
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Early Phase 3 Data Highlight Convenience and Feasibility of Self-Administered Alzheimer Agent Remternetug
2
New Phase 2 Trial to Test TREM2-Stabilizing Agent VHB937 in Alzheimer Disease
3
Alzheimer Trial PRImus-AD Tests Orally Available PRI-002 as New Treatment
4
CTAD Poster Shows Etalanetug Reduced Tau Pathology Biomarkers in Dominantly Inherited Alzheimer Disease
5
